David Mark ,Ph.D.
Chairman

Michael Chang, Ph.D.

Kenneth Chin, MD

Rev. David Chow

Ben Hsu, Ph.D

Richard Ohman, MBA

CEA ADVISORY BOARD:
The CEA Advisory Board is a group of highly-accomplished entrepreneurs, business professionals and Christian leaders whose focus is to maintain the highest quality of symposia, training materials, workshop/case studies and ethics database; for the members of CEA to participate in.

David Mark, Ph.D.
Dr. Mark is currently head of the High Throughput Screening at Hoffmann-La Roche. In this capacity, he is responsible for identifying new chemical leads for all projects in Preclinical Research & Development at the Nutley, New Jersey site. David earned his Bachelor_s degree in Chemistry at the University of Massachusetts (1973, Summa Cum Laude) and his Ph.D. in Biochemistry at Harvard Medical School (1977), where he worked with Dr. Charles Richardson on bacteriophage T7 DNA replication. He accepted a postdoctoral position at Stanford University Medical Center, Department of Biochemistry in the laboratory of Dr. Paul Berg (1977-79). He then spent ten years with Cetus Corporation, moving into positions of increasing responsibility in the Molecular Biology and New Therapeutics areas. In 1989, David accepted the Executive Director position at Merck & Co., and in the following ten years was responsible for various drug discovery programs, including Natural Products Discovery and Growth Factor Mimetics.

David has made several major contributions to science and medicine. He developed a novel modified Interleukin-2 recombinant protein for the treatment of renal cancer and melanoma. He also played a significant role in the development of a genetically modified Fibroblast Interferon for the treatment of Multiple Sclerosis. David also developed and patented a novel method for the quantitation of messenger RNA levels in single cells using a modification of the polymerase chain reaction.

David has published over 30 papers and holds 19 patents. He has been invited to present at numerous scientific meetings. David is the recipient of the Outstanding Young Scientist in America Award given by Science Digest Magazine (1984). He also received the Inventor of the Year Award (1986) given by Intellectual Properties Owners, Inc., for his role in the development of the genetically-engineered Interleukin-2 Muteins. He was a member of the Program Advisory Committee of the Biotechnology Research Institute, The Hong Kong University of Science and Technology (1990-93); and he was appointed as a Scientific Advisor of the China National Center for Biotechnology Development, Beijing, China (1984-87).
back to top

Michael Chang, Ph.D.
Dr. Chang is a co-founder of Optimer. Before joining Optimer as CEO, Dr. Chang was the Senior Vice President of Research and Development, Pharmanex, Inc., and Chief Scientific Officer of Nu Skin Enterprises. Dr. Chang was a co-founder of Pharmanex (purchased by Nu Skin Enterprise in 1998) with Dr. Carl Djerassi, the scientific co-founder of Syntex, and Bill McGlashan Jr., in 1994. Before Pharmanex, Dr. Chang worked for 15 years in pharmaceutical industry, at Merck, Rhone-Poulenc Rorer and ArQule, with steadily increased management responsibility. Dr. Chang holds 35 US patents and more than 60 publications. Dr. Chang holds a Ph.D degree in Organic Chemistry from Brandeis University and Post-doctoral training at MIT.

back to top

Rev. David T. Chow
Rev. David T. Chow is the executive director of Ambassadors for Christ, Inc. (AFC), an evangelical, Chinese Christian organization to reach Chinese students and professionals in the United States.

David T. Chow was born in 1949 in Indonesia, the son of Rev. and Mrs. Moses Chow, then missionaries from China working among the Indonesian, Japanese, and Chinese. At the age of 11 the family served in Japan. At the age of 13 he came to the United States. David accepted Christ in his early childhood and made public confession in his high school years.

Rev. Chow graduated from the University of Maryland in 1973 with a Bachelor of Arts degree in Business Administration. He attended the Graduate School of Bible and Missions at Columbia, SC where he received his Master of Arts degree in Bible and Missions in 1975. He served as pastoral staff at his home church in Maryland before joining the staff of Ambassadors for Christ in 1976. Rev. Chow has been Executive Director CEO of AFC since 1983. As Executive Director, Rev. Chow has been instrumental in starting Chinese Mission, a triennial Chinese missions convention held in Washington, DC since 1983. The conference has grown in size from 300 to 1800 with a vision to mobilize Chinese to be involved in the worldwide missions enterprise.

In his student days, Rev. Chow was instrumental in starting a Chinese Bible study group on the campus of University of Maryland. Forty Chinese students came to know Christ through the outreach of that Bible study group. He was chairman of the University of Maryland Bible Study Group and youth leader of his church. He was a Board member of the North America Congress of Chinese Evangelicals (NACOCE), a member of the Advisory Council of Tuscarora Inn in Mt. Bethel, PA, and an advisory pastor to a Chinese Church in suburban Philadelphia. Presently Rev. Chow serves on the Board of the Interdenominational Foreign Mission Association (IFMA) and The Evangelical Alliance Mission (TEAM).

In 1976 he married the former Karen Chin, of San Mateo, California. Karen was born in Hong Kong and came with her parents to the states at age 13. She received her BA degree and teaching credentials at the California State University, Sacramento. Besides serving together with David, Karen is involved in childrens ministry at the Chinese Bible Church of Lancaster. The Chows have four children; Dalen (1979), Daniel (1982), Dennis (1986), and Karissa (1994) and currently reside in Lancaster, PA. The Chows spent their sabbatical year living in Taiwan and Hong Kong in 1990.

As Executive Director for Ambassadors for Christ, Rev. Chow oversees the total operations and is a member of the Board of Directors. He also represents AFC by speaking at missions conferences, churches, and special meetings.

AFC is primarily a Chinese mission, "called by God, in cooperation with local churches, to evangelize and disciple Chinese students and professionals in the United States, to motivate and equip them to impact the culture for the Lord, and to mobilize and channel them into service of Christ as a vital force for God's Kingdom" (AFC mission statement). AFC is a member of the Evangelical Council for Financial Accountability (ECFA) and a member mission of the Interdenominational Foreign Mission Association (IFMA).
back to top

Ben Hsu, Ph.D.
T. BEN HSU, Ph.D., MBA joined QPS in 2003 as Vice President, Finance & Control, and was promoted to CFO in 2005. Ben was with Aventis Behring, a division of Aventis S.A., from 1999 to 2003. Before joining QPS, he was Director of Global Finance Administration at Aventis Behring. Prior to joining Aventis, he was with Lyondell Chemical Company (previously ARCO Chemical Company) through various functions, including R&D, Engineering, Business Development & Licensing, Manufacturing, Finance, Planning & Control, etc. Ben received his B.S. degree from National Taiwan University and Master and Ph.D. degrees from the University of Delaware, all in chemical engineering. He also earned an MBA in general administration and finance from Drexel University.

Back to the top

Richard Ohman, MBA
back to top